Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IMMUNOTHERAPY”

5,557 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,557 results

Testing effectiveness (Phase 2)Study completedNCT07329907
What this trial is testing

Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic

Who this might be right for
WartsHuman Papilloma Virus (HPV)
Benha University 126
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Study completedNCT03548467
What this trial is testing

Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Locally Advanced or Metastatic Solid Tumours
Nykode Therapeutics ASA 41
Not applicableUnknownNCT06349044
What this trial is testing

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

Who this might be right for
Her-2 Negative Adenocarcinoma of the Gastro-oesophageal Junction/Gastric AdenocarcinomaHepatocellular CarcinomaBiliary Tract Carcinoma+1 more
Zhejiang Cancer Hospital 120
Testing effectiveness (Phase 2)Study completedNCT01516307
What this trial is testing

Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects

Who this might be right for
Metastatic Breast Cancer
OBI Pharma, Inc 349
Not applicableStudy completedNCT03633500
What this trial is testing

Effectiveness of Oral Immunotherapy Among Preterm Babies

Who this might be right for
Feeding BehaviorLate-Onset Neonatal Sepsis
Al Adan Hospital Kuwait 48
Testing effectiveness (Phase 2)Study completedNCT00004211
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 17
Testing effectiveness (Phase 2)UnknownNCT05267392
What this trial is testing

Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy

Who this might be right for
Non-small Cell Lung Cancer
Instituto Portugues de Oncologia, Francisco Gentil, Porto 30
Testing effectiveness (Phase 2)Study completedNCT03562871
What this trial is testing

IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC

Who this might be right for
NSCLC
IO Biotech 109
Large-scale testing (Phase 3)Ended earlyNCT00676143
What this trial is testing

Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients

Who this might be right for
Alzheimer Disease
Pfizer 1,100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07827768
What this trial is testing

Phase 2 Study of AV-1959R in Individuals With Preclinical Alzheimer's Disease

Who this might be right for
Preclinical Alzheimer's DiseaseAlzheimer Disease
Institute for Molecular Medicine 160
Testing effectiveness (Phase 2)Study completedNCT02336815
What this trial is testing

Selinexor Treatment of Refractory Myeloma

Who this might be right for
Multiple Myeloma
Karyopharm Therapeutics Inc 202
Testing effectiveness (Phase 2)Ended earlyNCT00321308
What this trial is testing

Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Pfizer 36
Early research (Phase 1)Looking for participantsNCT06389591
What this trial is testing

RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)

Who this might be right for
Recurrent Glioblastoma
University of Florida 24
Large-scale testing (Phase 3)Study completedNCT00550550
What this trial is testing

Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)

Who this might be right for
RhinoconjunctivitisRhinitisConjunctivitis+1 more
ALK-Abelló A/S 345
Testing effectiveness (Phase 2)Looking for participantsNCT07462650
What this trial is testing

Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticAdenocarcinoma of Colon
Beijing Biotech 48
Testing effectiveness (Phase 2)Study completedNCT03558997
What this trial is testing

Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy

Who this might be right for
Allergic Rhinitis
Regeneron Pharmaceuticals 103
Testing effectiveness (Phase 2)Looking for participantsNCT07290010
What this trial is testing

The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Hebei Medical University Fourth Hospital 25
Early research (Phase 1)Study completedNCT02849210
What this trial is testing

A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea

Who this might be right for
Rhinoconjunctivitis
Roxall Medicina España S.A 47
Early research (Phase 1)Ended earlyNCT00185874
What this trial is testing

Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases

Who this might be right for
Liver Cancer
Stanford University 22
Next Page